Sign up to save your podcasts
Or
Share In Cognito #013 - Doug Drysale, CEO - Cybin Inc. NYSE: $CYBN
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
In Cognito #013 - Doug Drysale, CEO - Cybin Inc. NYSE: $CYBN
Doug talks about trading in public markets, coming from pharmaceutical experience, clinical models, and more.
In Cognito is a podcast designed to be authentic, relaxed, and provide deep insights and thought-provoking questions, minus all the technicalities.
Listen on Spotify:
https://open.spotify.com/show/5XBlwwnbAAbrRd5NgosS1n
Listen on Apple Music:
https://podcasts.apple.com/ca/podcast/in-cognito/id1542426020
Subscribe to the Playlist:
https://www.youtube.com/playlist?list=PLMj79P4l-kSl5YY6VA9mbkOxQPDrM5NE1
Doug DrysdaleCEO, Cybin $CYBN
An experienced Corporate Director and CEO: Doug has chaired the Board of a NASDAQ-listed company and, as CEO for the past 12 years, has built and turned-around 3 pharmaceutical companies. During Doug’s 30 years of experience in the healthcare sector, he has formed cohesive management teams, recruited board members, completed 15 corporate acquisitions across three continents and has raised $4 billion of both public and private capital. Doug holds a bachelor’s degree in Microbial and Molecular Biology from the University of East Anglia in the U.K. and was recognized as Entrepreneur of the Year by Ernst and Young, in 2012.
View all episodes
By Microdose Psychedelic InsightsDoug talks about trading in public markets, coming from pharmaceutical experience, clinical models, and more.
In Cognito is a podcast designed to be authentic, relaxed, and provide deep insights and thought-provoking questions, minus all the technicalities.
Listen on Spotify:
https://open.spotify.com/show/5XBlwwnbAAbrRd5NgosS1n
Listen on Apple Music:
https://podcasts.apple.com/ca/podcast/in-cognito/id1542426020
Subscribe to the Playlist:
https://www.youtube.com/playlist?list=PLMj79P4l-kSl5YY6VA9mbkOxQPDrM5NE1
Doug DrysdaleCEO, Cybin $CYBN
An experienced Corporate Director and CEO: Doug has chaired the Board of a NASDAQ-listed company and, as CEO for the past 12 years, has built and turned-around 3 pharmaceutical companies. During Doug’s 30 years of experience in the healthcare sector, he has formed cohesive management teams, recruited board members, completed 15 corporate acquisitions across three continents and has raised $4 billion of both public and private capital. Doug holds a bachelor’s degree in Microbial and Molecular Biology from the University of East Anglia in the U.K. and was recognized as Entrepreneur of the Year by Ernst and Young, in 2012.